151
|
Bicego M, Morassutto S, Hernandez VH, Morgutti M, Mammano F, D'Andrea P, Bruzzone R. Selective defects in channel permeability associated with Cx32 mutations causing X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 2006; 21:607-17. [PMID: 16442804 DOI: 10.1016/j.nbd.2005.09.005] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2005] [Revised: 09/04/2005] [Accepted: 09/09/2005] [Indexed: 11/17/2022] Open
Abstract
The X-linked form of Charcot-Marie-Tooth disease (CMTX) is caused by mutations in connexin32 (Cx32), a gap junction protein expressed by Schwann cells where it forms reflexive channels that allow the passage of ions and signaling molecules across the myelin sheath. Although most mutations result in loss of function, several studies have reported that some retain the ability to form homotypic intercellular channels. To gain insight into the molecular defect of three functional CMTX variants, S26L, Delta111-116 and R220stop, we have used several fluorescent tracers of different size and ionic charge to compare their permeation properties to those of wild-type Cx32. Although all mutations allowed the passage of the dye with the smallest molecular mass, they exhibited a clear reduction in the permeability of either one or all of the probes with respect to wild-type channels, as assessed by the percentage of injections showing dye coupling. These data reveal that a lower size cutoff distinguishes these functional CMTX variants from wild-type channels and suggest that this defect may be of pathophysiological relevance.
Collapse
Affiliation(s)
- Massimiliano Bicego
- Dipartimento di Biochimica, Biofisica e Chimica delle Macromolecole, University of Trieste, via Licio Giorgieri 1, 34127 Trieste, Italy
| | | | | | | | | | | | | |
Collapse
|
152
|
Jones SM, Jones TA, Johnson KR, Yu H, Erway LC, Zheng QY. A comparison of vestibular and auditory phenotypes in inbred mouse strains. Brain Res 2006; 1091:40-6. [PMID: 16499890 PMCID: PMC2859199 DOI: 10.1016/j.brainres.2006.01.066] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2005] [Revised: 01/12/2006] [Accepted: 01/13/2006] [Indexed: 10/25/2022]
Abstract
The purposes of this research were to quantify gravity receptor function in inbred mouse strains and compare vestibular and auditory function for strain- and age-matched animals. Vestibular evoked potentials (VsEPs) were collected for 19 inbred strains at ages from 35 to 389 days old. On average, C57BL/6J (35 to 190 days), BALB/cByJ, C3H/HeSnJ, CBA/J, and young LP/J mice had VsEP thresholds comparable to normal. Elevated VsEP thresholds were found for elderly C57BL/6J, NOD.NONH2(kb), BUB/BnJ, A/J, DBA/2J, NOD/LtJ, A/WySnJ, MRL/MpJ, A/HeJ, CAST/Ei, SJL/J, elderly LP/J, and CE/J. These results suggest that otolithic function varies among inbred strains and several strains displayed gravity receptor deficits by 90 days old. Auditory brainstem response (ABR) thresholds were compared to VsEP thresholds for 14 age-matched strains. C57BL/6J mice (up to 190 days) showed normal VsEPs with normal to mildly elevated ABR thresholds. Four strains (BUB/BnJ, NOD/LtJ, A/J, elderly LP/J) had significant hearing loss and elevated VsEP thresholds. Four strains (DBA/2J, A/WySnJ, NOD.NONH2(kb), A/HeJ) had elevated VsEP thresholds (including absent VsEPs) with mild to moderate elevations in ABR thresholds. Three strains (MRL/MpJ, Ce/J, SJL/J) had significant vestibular loss with no concomitant hearing loss. These results suggest that functional change in one sensory system does not obligate change in the other. We hypothesize that genes responsible for early onset hearing loss may affect otolithic function, yet the time course of functional change may vary. In addition, some genetic mutations may produce primarily gravity receptor deficits. Potential genes responsible for selective gravity receptor impairment demonstrated herein remain to be identified.
Collapse
Affiliation(s)
- Sherri M Jones
- Department of Communication Sciences and Disorders, East Carolina University, Belk Annex, Greenville and Charles Boulevards, Greenville, NC 27858, USA.
| | | | | | | | | | | |
Collapse
|
153
|
Shabbir MI, Ahmed ZM, Khan SY, Riazuddin S, Waryah AM, Khan SN, Camps RD, Ghosh M, Kabra M, Belyantseva IA, Friedman TB, Riazuddin S. Mutations of human TMHS cause recessively inherited non-syndromic hearing loss. J Med Genet 2006; 43:634-40. [PMID: 16459341 PMCID: PMC2564584 DOI: 10.1136/jmg.2005.039834] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Approximately half the cases of prelingual hearing loss are caused by genetic factors. Identification of genes causing deafness is a crucial first step in understanding the normal function of these genes in the auditory system. Recently, a mutant allele of Tmhs was reported to be associated with deafness and circling behaviour in the hurry-scurry mouse. Tmhs encodes a predicted tetraspan protein of unknown function, which is expressed in inner ear hair cells. The human homologue of Tmhs is located on chromosome 6p. OBJECTIVE To determine the cause of deafness in four consanguineous families segregating recessive deafness linked to markers on chromosome 6p21.1-p22.3 defining a novel DFNB locus. RESULTS A novel locus for non-syndromic deafness DFNB67 was mapped in an interval of approximately 28.51 cM on human chromosome 6p21.1-p22.3. DNA sequence analysis of TMHS revealed a homozygous frameshift mutation (246delC) and a missense mutation (Y127C) in affected individuals of two families segregating non-syndromic deafness, one of which showed significant evidence of linkage to markers in the DFNB67 interval. The localisation of mTMHS in developing mouse inner ear hair cells was refined and found to be expressed briefly from E16.5 to P3. CONCLUSIONS These findings establish the importance of TMHS for normal sound transduction in humans.
Collapse
Affiliation(s)
- M I Shabbir
- National Centre of Excellence in Molecular Biology, Punjab University, Thokar Niaz Baig, Lahore, Pakistan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
154
|
Petit C. From deafness genes to hearing mechanisms: harmony and counterpoint. Trends Mol Med 2006; 12:57-64. [PMID: 16406841 DOI: 10.1016/j.molmed.2005.12.006] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2005] [Revised: 11/28/2005] [Accepted: 12/23/2005] [Indexed: 10/25/2022]
Abstract
The study of hereditary hearing impairments provides a unique opportunity to deal with two objectives simultaneously: (i) identification of the causative genes and the underlying pathogenic process in each form of deafness; and (ii) elucidation of the molecular and cellular mechanisms of hearing. This review highlights the breakthroughs achieved during the past 12 years, with respect to their medical impacts and advances in basic scientific knowledge. To date, this research relies extensively on mouse models to study human forms of deafness. But, can mouse models sustain genetic approaches to study the physiology and pathophysiology of the auditory system and to develop and test drugs?
Collapse
Affiliation(s)
- Christine Petit
- Unité de Génétique des Déficits Sensoriels, INSERM U587, Institut Pasteur, 25 rue du Dr Roux, F-75724 Paris cedex 15, France.
| |
Collapse
|
155
|
Kharkovets T, Dedek K, Maier H, Schweizer M, Khimich D, Nouvian R, Vardanyan V, Leuwer R, Moser T, Jentsch TJ. Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness. EMBO J 2006; 25:642-52. [PMID: 16437162 PMCID: PMC1383535 DOI: 10.1038/sj.emboj.7600951] [Citation(s) in RCA: 194] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2005] [Accepted: 12/19/2005] [Indexed: 12/26/2022] Open
Abstract
KCNQ4 is an M-type K+ channel expressed in sensory hair cells of the inner ear and in the central auditory pathway. KCNQ4 mutations underlie human DFNA2 dominant progressive hearing loss. We now generated mice in which the KCNQ4 gene was disrupted or carried a dominant negative DFNA2 mutation. Although KCNQ4 is strongly expressed in vestibular hair cells, vestibular function appeared normal. Auditory function was only slightly impaired initially. It then declined over several weeks in Kcnq4-/- mice and over several months in mice carrying the dominant negative allele. This progressive hearing loss was paralleled by a selective degeneration of outer hair cells (OHCs). KCNQ4 disruption abolished the I(K,n) current of OHCs. The ensuing depolarization of OHCs impaired sound amplification. Inner hair cells and their afferent synapses remained mostly intact. These cells were only slightly depolarized and showed near-normal presynaptic function. We conclude that the hearing loss in DFNA2 is predominantly caused by a slow degeneration of OHCs resulting from chronic depolarization.
Collapse
Affiliation(s)
- Tatjana Kharkovets
- Zentrum für Molekulare Neurobiologie, ZMNH, Universität Hamburg, Hamburg, Germany
| | - Karin Dedek
- Zentrum für Molekulare Neurobiologie, ZMNH, Universität Hamburg, Hamburg, Germany
| | - Hannes Maier
- Department of Otolaryngology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - Michaela Schweizer
- Zentrum für Molekulare Neurobiologie, ZMNH, Universität Hamburg, Hamburg, Germany
| | - Darina Khimich
- Department of Otolaryngology, Center for Molecular Physiology of the Brain, University of Göttingen, Göttingen, Germany
| | - Régis Nouvian
- Department of Otolaryngology, Center for Molecular Physiology of the Brain, University of Göttingen, Göttingen, Germany
| | - Vitya Vardanyan
- Zentrum für Molekulare Neurobiologie, ZMNH, Universität Hamburg, Hamburg, Germany
| | - Rudolf Leuwer
- Department of Otolaryngology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - Tobias Moser
- Department of Otolaryngology, Center for Molecular Physiology of the Brain, University of Göttingen, Göttingen, Germany
| | - Thomas J Jentsch
- Zentrum für Molekulare Neurobiologie, ZMNH, Universität Hamburg, Hamburg, Germany
- Zentrum für Molekulare Neurobiologie, ZMNH, Universität Hamburg, Falkenried 94, Hamburg 20246, Germany. Tel.: +49 40 42803 4741; Fax: +49 40 42803 4839; E-mail:
| |
Collapse
|
156
|
Riazuddin S, Khan SN, Ahmed ZM, Ghosh M, Caution K, Nazli S, Kabra M, Zafar AU, Chen K, Naz S, Antonellis A, Pavan WJ, Green ED, Wilcox ER, Friedman PL, Morell RJ, Riazuddin S, Friedman TB. Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness. Am J Hum Genet 2006; 78:137-43. [PMID: 16385457 PMCID: PMC1380211 DOI: 10.1086/499164] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2005] [Accepted: 10/14/2005] [Indexed: 11/03/2022] Open
Abstract
In seven families, six different mutant alleles of TRIOBP on chromosome 22q13 cosegregate with autosomal recessive nonsyndromic deafness. These alleles include four nonsense (Q297X, R788X, R1068X, and R1117X) and two frameshift (D1069fsX1082 and R1078fsX1083) mutations, all located in exon 6 of TRIOBP. There are several alternative splice isoforms of this gene, the longest of which, TRIOBP-6, comprises 23 exons. The linkage interval for the deafness segregating in these families includes DFNB28. Genetic heterogeneity at this locus is suggested by three additional families that show significant evidence of linkage of deafness to markers on chromosome 22q13 but that apparently have no mutations in the TRIOBP gene.
Collapse
Affiliation(s)
- Saima Riazuddin
- Section on Human Genetics, Laboratory of Molecular Genetics, National Institute on Deafness and Other Communication Disorders, National Institutes of Health (NIH), Rockville, MD 20850, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
157
|
Neocleous V, Aspris A, Shahpenterian V, Nicolaou V, Panagi C, Ioannou I, Kyamides Y, Anastasiadou V, Phylactou LA. High Frequency of 35delG GJB2 Mutation and Absence of del(GJB6-D13S1830) in Greek Cypriot Patients with Nonsyndromic Hearing Loss. ACTA ACUST UNITED AC 2006; 10:285-9. [PMID: 17253936 DOI: 10.1089/gte.2006.10.285] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Mutations in the GJB2 (Connexin 26) gene are responsible for more than half of all cases of prelingual, recessive, inherited, nonsyndromic deafness in Europe. This paper presents a mutation analysis of the GJB2 and GJB6 (Connexin 30) genes in 30 Greek Cypriot patients with sensorineural nonsyndromic hearing loss compatible with recessive inheritance. Ten of the patients (33.3%) had the 35delG mutation in the GJB2 gene. Moreover, 9 of these were homozygous for the 35delG mutation, whereas 1 patient was in the compound heterozygous state with the disease causing E47X nonsense mutation. Another patient with severe sensorineural hearing loss was heterozygous for the V153I missense mutation. Finally, no GJB6 mutations or the known del(GJB6-D13S1830) were identified in any of the investigated Greek Cypriot nonsyndromic hearing loss patients. This work confirms that the GJB2 35delG mutation is an important pathogenic mutation for hearing loss in the Greek Cypriot population. This finding will be used toward the effective diagnosis of nonsyndromic hearing loss, improve genetic counseling, and serve as a potential therapeutic platform in the future for the affected patients in Cyprus.
Collapse
Affiliation(s)
- Vassos Neocleous
- Department of Molecular Genetics, The Cyprus Institute of Neurology and Genetics, 1683 Nicosia, Cyprus
| | | | | | | | | | | | | | | | | |
Collapse
|
158
|
Abstract
Connexins are a family of transmembrane proteins that form gap junctions between adjacent cells and allow intercellular communication. Connexin proteins are involved in pathological conditions in humans, mainly in hearing loss, neurodegenerative disorders and skin diseases. The association between connexin proteins and the inner ear is well established. The abundant expression of connexins in the auditory system of the inner ear demonstrates their importance in inner ear development and the hearing process. Most compelling, there are over 100 mutations in genes encoding connexins that are associated with deafness. Most prominent is the remarkable involvement of connexin 26 in hearing loss. Mutations in the gene GJB2, encoding connexin 26, are responsible for around 50% of genetic cases of severe to profound non-syndromic hearing loss in some parts of the world. Learning more about the connexin family in general and about connexin 26 in particular can shed light on the pathogenesis of the inner ear and bring us closer to finding clinical solutions for the hearing impaired.
Collapse
Affiliation(s)
- Adi D Sabag
- Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | | | | |
Collapse
|
159
|
Liu XZ, Pandya A, Angeli S, Telischi FF, Arnos KS, Nance WE, Balkany T. Audiological features of GJB2 (connexin 26) deafness. Ear Hear 2005; 26:361-9. [PMID: 15937416 DOI: 10.1097/00003446-200506000-00011] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE The aim of the present study was to characterize audiological profiles in patients with GJB2 deafness DESIGN We screened DNA from 399 individuals with nonsyndromic deafness for mutations in the connexin 26 gene (GJB2) by sequence analysis. A total of 77 (19%) of these deaf individuals were biallelic GJB2 mutations (either homozygous or compound heterozygous mutations) (GJB2 deafness). Using the audiological classification criteria of genetic deafness proposed by the European Workshop on Genetic Hearing Loss, we analyzed audiograms of these patients to characterize audiological features of the GJB2 deafness. In addition, we reviewed audiological data of 411 deafness cases from the literature providing details of audiological data (including 157 with GJB2 deafness). RESULTS All categories of hearing loss severity were found, with significant differences in the findings from GJB2 cases: 1 (4.5%) of 22 individuals with mild hearing loss, 10 (13.3%) of 75 with moderate loss, 14 (14.9%) of 94 with severe loss, and 52 (25%) of 208 with profound deafness (Chi-square test, 3 df, p = 0.016). 81.6% of patients with GJB2 mutations had severe to profound loss, 18.4% with mild to moderate loss (Chi-square test, p = 0.014). The 235delC mutation was always associated with profound deafness. The main audiogram shapes found were residual/sloping (72.7%) and flat (23.4%). There were no differences in the severity and audiogram shapes of the hearing impairment between homozygous and compound heterozygous GJB2 deafness (Chi-square test, p > 0.05). CONCLUSIONS Our study shows that the probability of finding biallelic GJB2 mutations increases with the severity of hearing loss. Audiograms associated with GJB2 deafness were usually nonspecific. Patients with unknown causes of severe or profound hearing loss should be routinely tested for GJB2 mutations, but due to the variability in hearing loss, individuals with lesser degrees of hearing loss should not be precluded from testing.
Collapse
Affiliation(s)
- Xue Zhong Liu
- Department of Otolaryngology, University of Miami, Miami, Florida 33136, USA
| | | | | | | | | | | | | |
Collapse
|
160
|
Beisel KW, Rocha-Sanchez SM, Morris KA, Nie L, Feng F, Kachar B, Yamoah EN, Fritzsch B. Differential expression of KCNQ4 in inner hair cells and sensory neurons is the basis of progressive high-frequency hearing loss. J Neurosci 2005; 25:9285-93. [PMID: 16207888 PMCID: PMC6725753 DOI: 10.1523/jneurosci.2110-05.2005] [Citation(s) in RCA: 97] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Human KCNQ4 mutations known as DFNA2 cause non-syndromic, autosomal-dominant, progressive high-frequency hearing loss in which the cellular and molecular basis is unclear. We provide immunofluorescence data showing that Kcnq4 expression in the adult cochlea has both longitudinal (base to apex) and radial (inner to outer hair cells) gradients. The most intense labeling is in outer hair cells at the apex and in inner hair cells as well as spiral ganglion neurons at the base. Spatiotemporal expression studies show increasing intensity of KCNQ4 protein labeling from postnatal day 21 (P21) to P120 mice that is most apparent in inner hair cells of the middle turn. We have identified four alternative splice variants of Kcnq4 in mice. The alternative use of exons 9-11 produces three transcript variants (v1-v3), whereas the fourth variant (v4) skips all three exons; all variants have the same amino acid sequence at the C termini. Both reverse transcription-PCR and quantitative PCR analyses demonstrate that these variants have differential expression patterns along the length of the mouse organ of Corti and spiral ganglion neurons. Our expression data suggest that the primary defect leading to high-frequency loss in DFNA2 patients may be attributable to high levels of the dysfunctional Kcnq4_v3 variant in the spiral ganglion and inner hair cells in the basal hook region. Progressive hearing loss associated with aging may result from an increasing mutational load expansion toward the apex in inner hair cells and spiral ganglion neurons.
Collapse
MESH Headings
- Animals
- Animals, Newborn
- Blotting, Northern/methods
- Cochlea/cytology
- Exons
- Ganglia, Spinal/cytology
- Gene Expression/physiology
- Gene Expression Regulation, Developmental/physiology
- Hair Cells, Auditory, Inner/metabolism
- Hearing Loss, High-Frequency/genetics
- Hearing Loss, High-Frequency/metabolism
- KCNQ Potassium Channels/genetics
- KCNQ Potassium Channels/metabolism
- Mice
- Mice, Inbred Strains
- Neurons, Afferent/metabolism
- RNA Splicing/genetics
Collapse
Affiliation(s)
- Kirk W Beisel
- Department of Biomedical Sciences, Creighton University, Omaha, Nebraska 68178, USA.
| | | | | | | | | | | | | | | |
Collapse
|
161
|
Holley MC. Keynote review: The auditory system, hearing loss and potential targets for drug development. Drug Discov Today 2005; 10:1269-82. [PMID: 16214671 DOI: 10.1016/s1359-6446(05)03595-6] [Citation(s) in RCA: 64] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
There is a huge potential market for the treatment of hearing loss. Drugs are already available to ameliorate predictable, damaging effects of excessive noise and ototoxic drugs. The biggest challenge now is to develop drug-based treatments for regeneration of sensory cells following noise-induced and age-related hearing loss. This requires careful consideration of the physiological mechanisms of hearing loss and identification of key cellular and molecular targets. There are many molecular cues for the discovery of suitable drug targets and a full range of experimental resources are available for initial screening through to functional analysis in vivo. There is now an unparalleled opportunity for translational research.
Collapse
Affiliation(s)
- Matthew C Holley
- Department of Biomedical Sciences, Addison Building, Western Bank, Sheffield S10 2TN, UK.
| |
Collapse
|
162
|
Alvarez A, del Castillo I, Villamar M, Aguirre LA, González-Neira A, López-Nevot A, Moreno-Pelayo MA, Moreno F. High prevalence of the W24X mutation in the gene encoding connexin-26 (GJB2) in Spanish Romani (gypsies) with autosomal recessive non-syndromic hearing loss. Am J Med Genet A 2005; 137A:255-8. [PMID: 16088916 DOI: 10.1002/ajmg.a.30884] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Molecular testing for mutations in the gene encoding connexin-26 (GJB2) at the DFNB1 locus has become the standard of care for genetic diagnosis and counseling of autosomal recessive non-syndromic hearing impairment (ARNSHI). The spectrum of mutations in GJB2 varies considerably among the populations, different alleles predominating in different ethnic groups. A cohort of 34 families of Spanish Romani (gypsies) with ARNSHI was screened for mutations in GJB2. We found that DFNB1 deafness accounts for 50% of all ARNSHI in Spanish gypsies. The predominating allele is W24X (79% of the DFNB1 alleles), and 35delG is the second most common allele (17%). An allele-specific PCR test was developed for the detection of the W24X mutation. By using this test, carrier frequencies were determined in two sample groups of gypsies from different Spanish regions (Andalusia and Catalonia), being 4% and 0%, respectively. Haplotype analysis for microsatellite markers closely flanking the GJB2 gene revealed five different haplotypes associated with the W24X mutation, all sharing the same allele from marker D13S141, suggesting that a founder effect for this mutation is responsible for its high prevalence among Spanish gypsies.
Collapse
Affiliation(s)
- Araceli Alvarez
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid, Spain
| | | | | | | | | | | | | | | |
Collapse
|
163
|
Alexandrino F, Sartorato EL, Marques-de-Faria AP, Steiner CE. G59S mutation in the GJB2 (connexin 26) gene in a patient with Bart-Pumphrey syndrome. Am J Med Genet A 2005; 136:282-4. [PMID: 15952212 DOI: 10.1002/ajmg.a.30822] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
164
|
Rzadzinska AK, Derr A, Kachar B, Noben-Trauth K. Sustained cadherin 23 expression in young and adult cochlea of normal and hearing-impaired mice. Hear Res 2005; 208:114-21. [PMID: 16005171 DOI: 10.1016/j.heares.2005.05.008] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2005] [Accepted: 05/30/2005] [Indexed: 12/01/2022]
Abstract
Cadherin 23 encodes a single-pass transmembrane protein with 27 extracellular cadherin-domains and localizes to stereocilia where it functions as an inter-stereocilia link. Cadherin 23-deficient mice show congenital deafness in combination with circling behavior as a result of organizational defects in the stereocilia hair bundle; common inbred mouse strains carrying the hypomorphic Cdh23(753A) allele are highly susceptible to sensorineural hearing loss. Here, we show that an antibody (N1086) directed against the intracellular carboxyterminus reacts specifically with cadherin 23 and detects with high sensitivity the isoform devoid of the peptide encoded by exon 68 (CDH23Delta68). Cochlea, vestibule, eye, brain and testis produce the CDH23Delta68 isoform in abundance and form moieties with different molecular weight due to variations in glycosylation content. In the cochlea, CDH23Delta68 expression is highest at postnatal day 1 (P1) and P7; expression is down regulated through P14 and P21 and persists at a low steady-state level throughout adulthood (P160). Furthermore, CDH23Delta68 expression levels in young and adult cochlea are similar among normal and hearing deficient strains (C3HeB/FeJ, C57BL/6J and BUB/BnJ). Finally, by immunofluorescence using an antibody (Pb240) specific for ectodomain 14, we show that cadherin 23 localizes to stereocilia during hair bundle development in late gestation and early postnatal days. Cadherin 23-specific labeling becomes weaker as the hair bundle matures but faint labeling concentrated near the top of stereocilia is still detectable at P35. No labeling of cochlea stereocilia was observed with N1086. In conclusion, our data describe a cadherin 23-specific antibody with high affinity to the CDH23Delta68 isoform, reveal a dynamic cochlea expression and localization profile and show sustained cadherin 23 levels in adult cochlea of normal and hearing-impaired mice.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Animals, Newborn
- Antibody Specificity
- Base Sequence
- Cadherins/chemistry
- Cadherins/genetics
- Cadherins/immunology
- Cadherins/metabolism
- Cochlea/embryology
- Cochlea/growth & development
- Cochlea/metabolism
- Cochlea/pathology
- DNA, Complementary/genetics
- Female
- Gene Expression Regulation, Developmental
- Glycosylation
- Hearing Loss, Sensorineural/genetics
- Hearing Loss, Sensorineural/metabolism
- Hearing Loss, Sensorineural/pathology
- Male
- Mice
- Mice, Inbred C3H
- Mice, Inbred CBA
- Mice, Knockout
- Mice, Mutant Strains
- Rats
- Rats, Sprague-Dawley
- Tissue Distribution
Collapse
Affiliation(s)
- Agnieszka K Rzadzinska
- Section on Structural Cell Biology, Laboratory of Cellular Biology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA
| | | | | | | |
Collapse
|
165
|
Etournay R, El-Amraoui A, Bahloul A, Blanchard S, Roux I, Pézeron G, Michalski N, Daviet L, Hardelin JP, Legrain P, Petit C. PHR1, an integral membrane protein of the inner ear sensory cells, directly interacts with myosin 1c and myosin VIIa. J Cell Sci 2005; 118:2891-9. [PMID: 15976448 DOI: 10.1242/jcs.02424] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
By using the yeast two-hybrid technique, we identified a candidate protein ligand of the myosin 1c tail, PHR1, and found that this protein can also bind to the myosin VIIa tail. PHR1 is an integral membrane protein that contains a pleckstrin homology (PH) domain. Myosin 1c and myosin VIIa are two unconventional myosins present in the inner ear sensory cells. We showed that PHR1 immunoprecipitates with either myosin tail by using protein extracts from cotransfected HEK293 cells. In vitro binding assays confirmed that PHR1 directly interacts with these two myosins. In both cases the binding involves the PH domain. In vitro interactions between PHR1 and the myosin tails were not affected by the presence or absence of Ca2+ and calmodulin. Finally, we found that PHR1 is able to dimerise. As PHR1 is expressed in the vestibular and cochlear sensory cells, its direct interactions with the myosin 1c and VIIa tails are likely to play a role in anchoring the actin cytoskeleton to the plasma membrane of these cells. Moreover, as both myosins have been implicated in the mechanotransduction slow adaptation process that takes place in the hair bundles, we propose that PHR1 is also involved in this process.
Collapse
Affiliation(s)
- Raphaël Etournay
- Unité de Génétique des Déficits Sensoriels, INSERM U587, Institut Pasteur, 25 rue du Dr Roux, 75015 Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
166
|
|
167
|
van Steensel MAM. Gap junction diseases of the skin. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS 2005; 131C:12-9. [PMID: 15468169 DOI: 10.1002/ajmg.c.30030] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Gap junctions are intercellular channels that allow the passage of water, ions, and small molecules. They are involved in quick, short-range messaging between cells and are found in skin, nervous tissue, heart, and muscle. An increasing number of hereditary skin disorders appear to be caused by mutations in one of the genes coding for the constituent proteins of gap junctions, known as connexins. In this review, the currently known connexin disorders that feature skin abnormalities are described: keratitis-ichthyosis deafness syndrome, erythrokeratoderma variabilis, Vohwinkel's syndrome, and a novel disorder called hypotrichosis-deafness syndrome. What is known about the pathogenesis of these disorders is discussed and related to gap junction physiology.
Collapse
Affiliation(s)
- M A M van Steensel
- Dermatology Department, University Hospital Maastricht, the Netherlands.
| |
Collapse
|
168
|
|
169
|
Belintani Piatto V, Maria Goloni Bertollo E, Lúcia Sartorato E, Victor Maniglia J. Prevalence of the GJB2 mutations and the del(GJB6-D13S1830) mutation in Brazilian patients with deafness. Hear Res 2005; 196:87-93. [PMID: 15464305 DOI: 10.1016/j.heares.2004.05.007] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2003] [Accepted: 05/25/2004] [Indexed: 11/25/2022]
Abstract
Mutations in the GJB2 gene are the most common cause of sensorineural non-syndromic deafness in different populations. One specific mutation, 35delG, has accounted for the majority of the mutations detected in the GJB2 gene in many countries. The aim of this study was to determine the prevalence of GJB2 mutations and the del(GJB6-D13S1830) mutation in non-syndromic deaf Brazilians. The 33 unrelated probands were examined by clinical evaluation to exclude syndromic forms of deafness. Mutation analysis in the GJB2 gene and the testing for the del(GJB6-D13S1830) were performed in both the patients and their family members. The 35delG mutation was found in nine of the probands or in 14 of the mutated alleles. The V37I mutation and the del(GJB6-D13S1830) mutation were also found in two patients, both are compound heterozygote with 35delG mutation. These findings strengthen the importance of genetic diagnosis, providing early treatment, and genetic counseling of deaf patients.
Collapse
Affiliation(s)
- Vânia Belintani Piatto
- Medical School of São José do Rio Preto, Rua Frei Baltazar, No. 415, Boa Vista, São José do Rio Preto, São Paulo 15025-390, Brazil.
| | | | | | | |
Collapse
|
170
|
Reisinger E, Zimmermann U, Knipper M, Ludwig J, Klöcker N, Fakler B, Oliver D. Cod106, a novel synaptic protein expressed in sensory hair cells of the inner ear and in CNS neurons. Mol Cell Neurosci 2005; 28:106-17. [PMID: 15607946 DOI: 10.1016/j.mcn.2004.08.018] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2004] [Revised: 07/23/2004] [Accepted: 08/30/2004] [Indexed: 10/26/2022] Open
Abstract
The exquisite performance of the highly specialized mammalian inner ear requires a multitude of specific proteins. Yet, only a subset of these proteins has been identified and studied in detail. Here, we describe a novel gene expressed in the organ of Corti that encodes a membrane-associated protein of 106 kDa. The new protein, termed Cod106, lacks sequence homology to characterized gene products. As shown by in situ hybridization, it is expressed in auditory and vestibular hair cells, as well as in distinct sets of CNS neurons with particularly high abundance in hippocampus and cerebellum. Immunohistochemistry detected Cod106 at the basal, synaptic pole of cochlear outer hair cells and vestibular hair cells. In cultured hippocampal neurons, Cod106 immunofluorescence co-localized with the postsynaptic density protein 95 (PSD95), indicating a postsynaptic localization. Cell-type specificity and subcellular localization may be consistent with an involvement of Cod106 in synaptic processes.
Collapse
Affiliation(s)
- Ellen Reisinger
- Department of Physiology II, University of Freiburg, 79104 Freiburg, Germany
| | | | | | | | | | | | | |
Collapse
|
171
|
Kitajiri SI, Fukumoto K, Hata M, Sasaki H, Katsuno T, Nakagawa T, Ito J, Tsukita S, Tsukita S. Radixin deficiency causes deafness associated with progressive degeneration of cochlear stereocilia. ACTA ACUST UNITED AC 2004; 166:559-70. [PMID: 15314067 PMCID: PMC2172208 DOI: 10.1083/jcb.200402007] [Citation(s) in RCA: 113] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Ezrin/radixin/moesin (ERM) proteins cross-link actin filaments to plasma membranes to integrate the function of cortical layers, especially microvilli. We found that in cochlear and vestibular sensory hair cells of adult wild-type mice, radixin was specifically enriched in stereocilia, specially developed giant microvilli, and that radixin-deficient (Rdx−/−) adult mice exhibited deafness but no obvious vestibular dysfunction. Before the age of hearing onset (∼2 wk), in the cochlea and vestibule of Rdx−/− mice, stereocilia developed normally in which ezrin was concentrated. As these Rdx−/− mice grew, ezrin-based cochlear stereocilia progressively degenerated, causing deafness, whereas ezrin-based vestibular stereocilia were maintained normally in adult Rdx−/− mice. Thus, we concluded that radixin is indispensable for the hearing ability in mice through the maintenance of cochlear stereocilia, once developed. In Rdx−/− mice, ezrin appeared to compensate for radixin deficiency in terms of the development of cochlear stereocilia and the development/maintenance of vestibular stereocilia. These findings indicated the existence of complicate functional redundancy in situ among ERM proteins.
Collapse
Affiliation(s)
- Shin-ichiro Kitajiri
- Department of Cell Biology, Kyoto University Faculty of Medicine, Yoshida-Konoe, Sakyo-ku, Kyoto 606-8501, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
172
|
Kappler JA, Starr CJ, Chan DK, Kollmar R, Hudspeth AJ. A nonsense mutation in the gene encoding a zebrafish myosin VI isoform causes defects in hair-cell mechanotransduction. Proc Natl Acad Sci U S A 2004; 101:13056-61. [PMID: 15317943 PMCID: PMC516516 DOI: 10.1073/pnas.0405224101] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
In a three-generation screen of chemically mutagenized zebrafish, we identified a group of mutations that affect the development and function of hair cells, the mechanically sensitive cells of the inner ear and lateral-line organ. One mutant line, ru920, was discovered in a behavioral screen for defects in the acoustically evoked escape response. Despite apparently normal numbers of hair cells, mutants lack an inner-ear microphonic potential and exhibit reduced labeling of hair cells by a fluorophore that traverses transduction channels. This hair-cell-specific phenotype suggested a defect in the mechanoelectrical transduction apparatus. Positional cloning revealed that the recessive mutation introduces a premature stop codon in the ORF of myosin6b (myo6b), one of the two zebrafish orthologs of the human gene myosin VI. The ru920 line therefore provides an animal model with which to study the role of class VI myosin proteins in mechanotransduction.
Collapse
Affiliation(s)
- James A Kappler
- Howard Hughes Medical Institute, Laboratory of Sensory Neuroscience, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
| | | | | | | | | |
Collapse
|
173
|
Sidi S, Busch-Nentwich E, Friedrich R, Schoenberger U, Nicolson T. gemini encodes a zebrafish L-type calcium channel that localizes at sensory hair cell ribbon synapses. J Neurosci 2004; 24:4213-23. [PMID: 15115817 PMCID: PMC6729292 DOI: 10.1523/jneurosci.0223-04.2004] [Citation(s) in RCA: 79] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
L-type Ca2+ channels (LTCCs) drive the bulk of voltage-gated Ca2+ entry in vertebrate inner ear hair cells (HCs) and are essential for mammalian auditory processing. LTCC currents have been implicated in neurotransmitter release at the HC afferent active zone, the ribbon synapse. It is likely that LTCCs play a direct role in vesicle fusion; however, the subcellular localization of the channels in HCs has not been fully resolved. Via positional cloning, we show that mutations in a zebrafish LTCC encoding gene, cav1.3a, underlie the auditory-vestibular defects of gemini (gem) circler mutants. gem homozygous receptor mutant HCs display normal cell viability, afferent synaptogenesis, and peripheral innervation, yet exhibit strongly reduced extracellular potentials (approximately 50% of wild-type potentials). Apical FM1-43 uptake, however, is unaffected in gem mutant HCs, suggesting that mechanotransduction channels are functional. Using a Gem-specific antibody, we show that the bulk of Gem/Ca(v)1.3a immunoreactivity in HCs is restricted to basally located focal spots. The number and location of focal spots relative to nerve terminals, and their remarkable ring-shaped structure, which is reminiscent of synaptic dense bodies, are consistent with Gem/Ca(v)1.3a channels clustering at HC ribbon synapses.
Collapse
Affiliation(s)
- Samuel Sidi
- Max-Planck-Institut für Entwicklungsbiologie, 72076 Tübingen, Germany
| | | | | | | | | |
Collapse
|
174
|
Wattanasirichaigoon D, Limwongse C, Jariengprasert C, Yenchitsomanus PT, Tocharoenthanaphol C, Thongnoppakhun W, Thawil C, Charoenpipop D, Pho-iam T, Thongpradit S, Duggal P. High prevalence of V37I genetic variant in the connexin-26 (GJB2) gene among non-syndromic hearing-impaired and control Thai individuals. Clin Genet 2004; 66:452-60. [PMID: 15479191 DOI: 10.1111/j.1399-0004.2004.00325.x] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Hearing loss is highly prevalent with a worldwide incidence of 1-2 per 1000 newborns. Several previous studies have demonstrated that mutations of connexin 26 (Cx26 or GJB2) are responsible for most cases of the recessive non-syndromic sensorineural hearing loss (NSSHL). Certain mutations have been described frequently among various populations, which include 35delG, 167delT, and 235delC. Recently, a missense mutation, V37I, was reported as a pathogenic change in East Asian affected individuals. To identify genetic variants associated with NSSHL in Thai population, we performed mutation analysis of Cx26 in 166 unrelated probands with NSSHL and 205 controls. We identified seven novel genetic variants in Cx26. We also identified a high prevalence of the V37I mutation among both affected probands (11.1%) and control subjects (8.5%), which suggests that the pathologic role of V37I may be modified by other genes. Our data support previous studies that show heterogeneity in the frequencies and types of mutations in Cx26 within populations and among ethnicities and that before clinical significance and causality can be attributed to a genetic variant, functional characterization is necessary.
Collapse
Affiliation(s)
- D Wattanasirichaigoon
- Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
175
|
Hertzano R, Montcouquiol M, Rashi-Elkeles S, Elkon R, Yücel R, Frankel WN, Rechavi G, Möröy T, Friedman TB, Kelley MW, Avraham KB. Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene. Hum Mol Genet 2004; 13:2143-53. [PMID: 15254021 DOI: 10.1093/hmg/ddh218] [Citation(s) in RCA: 150] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Pou4f3 (Brn3.1, Brn3c) is a class IV POU domain transcription factor that has a central function in the development of all hair cells in the human and mouse inner ear sensory epithelia. A mutation of POU4F3 underlies human autosomal dominant non-syndromic progressive hearing loss DFNA15. Through a comparison of inner ear gene expression profiles of E16.5 wild-type and Pou4f3 mutant deaf mice using a high density oligonucleotide microarray, we identified the gene encoding growth factor independence 1 (Gfi1) as a likely in vivo target gene regulated by Pou4f3. To validate this result, we performed semi-quantitative RT-PCR and in situ hybridizations for Gfi1 on wild-type and Pou4f3 mutant mice. Our results demonstrate that a deficiency of Pou4f3 leads to a statistically significant reduction in Gfi1 expression levels and that the dynamics of Gfi1 mRNA abundance closely follow the pattern of expression for Pou4f3. To examine the role of Gfi1 in the pathogenesis of Pou4f3-related deafness, we performed comparative analyses of the embryonic inner ears of Pou4f3 and Gfi1 mouse mutants using immunohistochemistry and scanning electron microscopy. The loss of Gfi1 results in outer hair cell degeneration, which appears comparable to that observed in Pou4f3 mutants. These results identify Gfi1 as the first downstream target of a hair cell specific transcription factor and suggest that outer hair cell degeneration in Pou4f3 mutants is largely or entirely a result of the loss of expression of Gfi1.
Collapse
Affiliation(s)
- Ronna Hertzano
- Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
176
|
Meşe G, Londin E, Mui R, Brink PR, White TW. Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet 2004; 115:191-9. [PMID: 15241677 DOI: 10.1007/s00439-004-1142-6] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2004] [Accepted: 04/21/2004] [Indexed: 11/29/2022]
Abstract
Connexins (Cx) form gap junctions that allow the exchange of small metabolites and ions. In the inner ear, Cx26 is the major gap junction protein and mutations in the Cx26-encoding gene, GJB2, are the most frequent cause of autosomal recessive non-syndromic hearing loss (DFNB1). We have functionally analyzed five Cx26 mutations associated with DFNB1, comprising the following single amino-acid substitutions: T8M, R143W, V153I, N206S and L214P. Coupling of cells expressing wild-type or mutant Cx26 was measured in the paired Xenopus oocyte assay. We found that the R143W, V153I and L214P mutations were unable to form functional channels. In contrast, the T8M and N206S mutants did electrically couple cells, though their voltage gating properties were different from wild-type Cx26 channels. The electrical coupling of oocytes expressing the T8M and N206S mutants suggest that these channels may retain high permeability to potassium ions. Therefore, deafness associated with Cx26 mutations may not only depend on reduced potassium re-circulation in the inner ear. Instead, abnormalities in the exchange of other metabolites through the cochlear gap junction network may also produce deafness.
Collapse
Affiliation(s)
- Gülistan Meşe
- Graduate Program in Genetics, State University of New York, BST 5-147, NY 11794-8661, Stony Brook, USA
| | | | | | | | | |
Collapse
|
177
|
Cohn E, Bhattacharya G, Pearsall N, Shendrik I, Kimberling W, Cosgrove D. Immunohistochemistry and Reverse Transcriptase???Polymerase Chain Reaction as Methods for Diagnostic Determination of Usher Syndrome Type IIa. Laryngoscope 2004; 114:1310-4. [PMID: 15235367 DOI: 10.1097/00005537-200407000-00032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVES/HYPOTHESIS Patients having null mutations in the USH2A gene do not produce usherin and therefore are not positive for immunohistochemical staining of the usherin protein. Thus, immunostaining for usherin can serve as a reliable diagnostic tool for Usher syndrome type IIa. STUDY DESIGN Prospective. METHODS Immunohistochemical staining for usherin was carried out in basement membrane of minor salivary gland tissue from subjects with confirmed Usher syndrome type IIa and from archival minor salivary gland tissue from patients without Usher syndrome as control samples. Quantitative usherin messenger RNA analysis was performed using minor salivary gland biopsy tissue. RESULTS Five subjects with Usher syndrome type IIa had no immunostaining in minor salivary gland tissue, whereas control minor salivary gland tissue did stain with usherin antibody. No usherin RNA was detected in biopsy specimens from patients with confirmed Usher syndrome IIa. CONCLUSION The feasibility was confirmed of diagnosing Usher syndrome type IIa using purified usherin antibody in subjects having two null USH2A mutations.
Collapse
Affiliation(s)
- Edward Cohn
- Usher Syndrome Center, Boys Town National Research Hospital, Omaha, NE 68131, USA
| | | | | | | | | | | |
Collapse
|
178
|
Abstract
Linkage analysis in families with hereditary hearing loss have revealed a plethora of chromosomal locations linked to deafness reflecting the extreme heterogeneity of the disorder. 40 of the genes contained within these loci have been mapped lending an insight into the diverse molecules operating in the inner ear and the remarkable complexity of the cellular and molecular processes involved in the transucdation of sound in the auditory system. Among this diversity, Connexin 26 has been found to be the most common cause of deafness the world around. The authors review here the prevalence of this gene in the Indian population as found in their study, together with other deafness genes segregating non-syndromic deafness, accounting for approximately 40% of all cases. This indicates there are several more to be identified yet. Knowledge of the genetic cause of deafness in our families is important for accurate genetic counseling and early diagnosis for timely intervention and treatment options.
Collapse
Affiliation(s)
- Manju Ghosh
- Genetics Unit, Department of Pediatrics, All India, Institute of Medical Sciences, New Delhi, India
| | | | | |
Collapse
|
179
|
Gerido DA, White TW. Connexin disorders of the ear, skin, and lens. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2004; 1662:159-70. [PMID: 15033586 DOI: 10.1016/j.bbamem.2003.10.017] [Citation(s) in RCA: 112] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/16/2003] [Revised: 10/08/2003] [Accepted: 10/08/2003] [Indexed: 12/31/2022]
Abstract
Gap junctions provide coupled cells with a direct pathway for sharing ions, nutrients, and small metabolites, thus helping to maintain homeostasis in various tissues. Abnormal function and/or expression of specific connexin genes has been linked to several diseases, including genetic deafness, skin disease, peripheral neuropathies, and cataracts. Research has provided significant insight into the function of gap junction proteins in both in vitro and in vivo models; however, questions regarding the exact mechanisms by which connexin related diseases occur in mammalian systems remain. Here, we discuss the disease states that are related to three human connexin genes, Cx26 (GJB2), Cx46 (GJA3) and Cx50 (GJA8), and recent scientific evidence characterizing those diseases in various experimental models.
Collapse
Affiliation(s)
- Dwan A Gerido
- Department of Physiology and Biophysics, State University of New York, T5-147, Basic Science Tower, Stony Brook, NY 11794-8661, USA
| | | |
Collapse
|
180
|
Hardelin JP, Denoyelle F, Levilliers J, Simmler MC, Petit C. Les surdités héréditaires : génétique moléculaire. Med Sci (Paris) 2004; 20:311-6. [PMID: 15067576 DOI: 10.1051/medsci/2004203311] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
This article outlines recent advances in explaining hereditary deafness in molecular terms, focusing on isolated (i.e. nonsyndromic) hearing loss. The number of genes identified (36 to date) is growing rapidly. However, difficulties inherent in genetic linkage analysis, coupled with the possible involvement of environmental causes, have so far prevented the characterization of the main genes causative or predisposing to the late-onset forms of deafness.
Collapse
Affiliation(s)
- Jean-Pierre Hardelin
- Unité de génétique des déficits sensoriels, Inserm U.587, Institut Pasteur, 25, rue du Docteur Roux, 75724 Paris Cedex 15, France
| | | | | | | | | |
Collapse
|
181
|
Christ S, Biebel UW, Hoidis S, Friedrichsen S, Bauer K, Smolders JWT. Hearing Loss in Athyroid Pax8 Knockout Mice and Effects of Thyroxine Substitution. Audiol Neurootol 2004; 9:88-106. [PMID: 14981357 DOI: 10.1159/000076000] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2003] [Accepted: 10/02/2003] [Indexed: 11/19/2022] Open
Abstract
Pax8-/- mice do not develop thyroid follicular structures and thus provide an ideal animal model to study the consequences of congenital hypothyroidism. Despite their athyroidism, Pax8-/- mice survive up to postnatal day 21 (P21). No auditory brain stem responses (ABR) to sound could be recorded in these animals at 130 dB SPL, even at P21, when hearing reaches adult sensitivity in control mice. Abnormalities in the outer and middle ear structures were found in a considerable percentage of Pax8-/- animals. Maturation of the inner ear appeared delayed by about 1 week with respect to euthyroid controls. Hearing of adult Pax8-/- mice could be nearly normalized by early postnatal substitution with thyroxine (T(4)), but structural and functional restoration of hearing was incomplete. Even when T(4) substitution was initiated at P1, ABR thresholds, measured at 6 weeks of age or more, were increased by about 20 dB, and each day of delay in the start of T(4) substitution resulted in an additional threshold loss of about 4 dB. The most prominent structural deficit in Pax8-/- animals in which T(4) substitution was started at P8 or later was an abnormally thick tectorial membrane. In these late-substituted animals, disarray of stereovilli from inner and outer hair cells was observed and also outer hair cell loss was found, predominantly in the basal part of the cochlea. The degree of structural disorder increased the later T(4) substitution was initiated. The structural and functional consequences of postnatal athyroidism observed in Pax8-/- mice are largely in agreement with and extend those data obtained from hypothyroid animal models in which hypothyroidism was induced by goitrogenic agents (methimazole, propylthiouracil) or animal models with disrupted genes for the TSH receptor or the thyroid hormone receptors. The hearing loss and also the recovery effect by T(4) substitution in Pax8-/- mice is larger than that in the other models. Although Pax8-/- mice are born by euthyroid Pax8+/- dams, the Pax8-/- phenotype could not be completely restored by immediate postnatal T(4) substitution, indicating that some deficits are the consequence of prenatal T(4) deficiency of the offspring.
Collapse
Affiliation(s)
- Stephanie Christ
- Max-Planck-Institut für experimentelle Endokrinologie, Hannover, Germany
| | | | | | | | | | | |
Collapse
|
182
|
Busch-Nentwich E, Söllner C, Roehl H, Nicolson T. The deafness genedfna5is crucial forugdhexpression and HA production in the developing ear in zebrafish. Development 2004; 131:943-51. [PMID: 14736743 DOI: 10.1242/dev.00961] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Over 30 genes responsible for human hereditary hearing loss have been identified during the last 10 years. The proteins encoded by these genes play roles in a diverse set of cellular functions ranging from transcriptional regulation to K+ recycling. In a few cases, the genes are novel and do not give much insight into the cellular or molecular cause for the hearing loss. Among these poorly understood deafness genes is DFNA5. How the truncation of the encoded protein DFNA5 leads to an autosomal dominant form of hearing loss is not clear. In order to understand the biological role of Dfna5, we took a reversegenetic approach in zebrafish. Here we show that morpholino antisense nucleotide knock-down of dfna5 function in zebrafish leads to disorganization of the developing semicircular canals and reduction of pharyngeal cartilage. This phenotype closely resembles previously isolated zebrafish craniofacial mutants including the mutant jekyll. jekyll encodes Ugdh [uridine 5′-diphosphate (UDP)-glucose dehydrogenase], an enzyme that is crucial for production of the extracellular matrix component hyaluronic acid (HA). In dfna5 morphants, expression of ugdh is absent in the developing ear and pharyngeal arches, and HA levels are strongly reduced in the outgrowing protrusions of the developing semicircular canals. Previous studies suggest that HA is essential for differentiating cartilage and directed outgrowth of the epithelial protrusions in the developing ear. We hypothesize that the reduction of HA production leads to uncoordinated outgrowth of the canal columns and impaired facial cartilage differentiation.
Collapse
|
183
|
Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, Bai Y, Young WY, Guan MX. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet 2004; 74:139-52. [PMID: 14681830 PMCID: PMC1181901 DOI: 10.1086/381133] [Citation(s) in RCA: 271] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2003] [Accepted: 10/29/2003] [Indexed: 11/03/2022] Open
Abstract
We report here the characterization of a large Chinese family with maternally transmitted aminoglycoside-induced and nonsyndromic deafness. In the absence of aminoglycosides, some matrilineal relatives in this family exhibited late-onset/progressive deafness, with a wide range of severity and age at onset. Notably, the average age at onset of deafness has changed from 55 years (generation II) to 10 years (generation IV). Clinical data reveal that the administration of aminoglycosides can induce or worsen deafness in matrilineal relatives. The age at the time of drug administration appears to be correlated with the severity of hearing loss experienced by affected individuals. Sequence analysis of mitochondrial DNA in this pedigree identified a homoplasmic C-to-T transition at position 1494 (C1494T) in the 12S rRNA gene. The C1494T mutation is expected to form a novel U1494-1555A base pair, which is in the same position as the C1494-1555G pair created by the deafness-associated A1555G mutation, at the highly conserved A site of 12S rRNA. Exposure to a high concentration of paromomycin or neomycin caused a variable but significant average increase in doubling time in lymphoblastoid cell lines derived from four symptomatic and two asymptomatic individuals in this family carrying the C1494T mutation when compared to four control cell lines. Furthermore, a significant decrease in the rate of total oxygen consumption was observed in the mutant cell lines. Thus, our data strongly support the idea that the A site of mitochondrial 12S rRNA is the primary target for aminoglycoside-induced deafness. These results also strongly suggest that the nuclear background plays a role in the aminoglycoside ototoxicity and in the development of the deafness phenotype associated with the C1494T mutation in the mitochondrial 12S rRNA gene.
Collapse
Affiliation(s)
- Hui Zhao
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Ronghua Li
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Qiuju Wang
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Qingfeng Yan
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Jian-Hong Deng
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Dongyi Han
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Yidong Bai
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Wie-Yen Young
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| | - Min-Xin Guan
- Division and Program in Human Genetics and Center for Hearing and Deafness Research, Cincinnati Children’s Hospital Medical Center, Cincinnati; Department of Otolaryngology, Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing; and Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio
| |
Collapse
|
184
|
del Castillo I, Moreno-Pelayo MA, del Castillo FJ, Brownstein Z, Marlin S, Adina Q, Cockburn DJ, Pandya A, Siemering KR, Chamberlin GP, Ballana E, Wuyts W, Maciel-Guerra AT, Álvarez A, Villamar M, Shohat M, Abeliovich D, Dahl HHM, Estivill X, Gasparini P, Hutchin T, Nance WE, Sartorato EL, Smith RJH, Van Camp G, Avraham KB, Petit C, Moreno F. Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study. Am J Hum Genet 2003; 73:1452-8. [PMID: 14571368 PMCID: PMC1180408 DOI: 10.1086/380205] [Citation(s) in RCA: 226] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2003] [Accepted: 09/25/2003] [Indexed: 11/03/2022] Open
Abstract
Mutations in GJB2, the gene encoding connexin-26 at the DFNB1 locus on 13q12, are found in as many as 50% of subjects with autosomal recessive, nonsyndromic prelingual hearing impairment. However, genetic diagnosis is complicated by the fact that 10%-50% of affected subjects with GJB2 mutations carry only one mutant allele. Recently, a deletion truncating the GJB6 gene (encoding connexin-30), near GJB2 on 13q12, was shown to be the accompanying mutation in approximately 50% of these deaf GJB2 heterozygotes in a cohort of Spanish patients, thus becoming second only to 35delG at GJB2 as the most frequent mutation causing prelingual hearing impairment in Spain. Here, we present data from a multicenter study in nine countries that shows that the deletion is present in most of the screened populations, with higher frequencies in France, Spain, and Israel, where the percentages of unexplained GJB2 heterozygotes fell to 16.0%-20.9% after screening for the del(GJB6-D13S1830) mutation. Our results also suggest that additional mutations remain to be identified, either in DFNB1 or in other unlinked genes involved in epistatic interactions with GJB2. Analysis of haplotypes associated with the deletion revealed a founder effect in Ashkenazi Jews and also suggested a common founder for countries in Western Europe. These results have important implications for the diagnosis and counseling of families with DFNB1 deafness.
Collapse
Affiliation(s)
- Ignacio del Castillo
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Miguel A. Moreno-Pelayo
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Francisco J. del Castillo
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Zippora Brownstein
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Sandrine Marlin
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Quint Adina
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - David J. Cockburn
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Arti Pandya
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Kirby R. Siemering
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - G. Parker Chamberlin
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Ester Ballana
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Wim Wuyts
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Andréa Trevas Maciel-Guerra
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Araceli Álvarez
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Manuela Villamar
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Mordechai Shohat
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Dvorah Abeliovich
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Hans-Henrik M. Dahl
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Xavier Estivill
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Paolo Gasparini
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Tim Hutchin
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Walter E. Nance
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Edi L. Sartorato
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Richard J. H. Smith
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Guy Van Camp
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Karen B. Avraham
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Christine Petit
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| | - Felipe Moreno
- Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid; Unité de Génétique des Déficits Sensoriels INSERM U587, Institut Pasteur, and Unité de Génétique Médicale, Hôpital Trousseau, Paris; Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv; Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem; DNA Laboratory and Molecular Medicine Unit, St. James's University Hospital, Leeds, United Kingdom; Department of Human Genetics, Medical College of Virginia of Virginia Commonwealth University, Richmond; The Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne; Interdepartmental Human Genetics Program and the Department of Otolaryngology, University of Iowa, Iowa City; Genes and Disease Program, Center for Genomic Regulation, Pompeu Fabra University, Barcelona; Department of Medical Genetics, University of Antwerp, Antwerp; Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Sâo Paulo, Brazil; Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; and Medical Genetics, Second University of Naples and Telethon Institute of Genetics and Medicine, Naples
| |
Collapse
|
185
|
Abstract
Stress of some kind is encountered everyday and release of stress hormones is essential for adaptation to change. Stress can be physical (pain, noise exposure, etc.), psychological (apprehension to impending events, acoustic conditioning, etc.) or due to homeostatic disturbance (hunger, blood pressure, inner ear pressure, etc.). Persistent elevated levels of stress hormones can lead to disease states. The aim of the present review is to bring together data describing morphological or functional evidence for hormones of stress within the inner ear. The present review describes possible multiple interactions between the sympathetic and the complex feed-back neuroendocrine systems which interact with the immune system and so could contribute to various inner ear dysfunctions such as tinnitus, vertigo, hearing losses. Since there is a rapidly expanding list of genes specifically expressed within the inner ear this clearly allows for possible genomic and non-genomic local action of steroid hormones. Since stress can be encountered at any time throughout the life-time, the effects might be manifested starting from in-utero. These are avenues of research which remain relatively unexplored which merit further consideration. Progress in this domain could lead towards integration of stress concept into the overall clinical management of various inner ear pathologies.
Collapse
Affiliation(s)
- K C Horner
- Equipe Inserm EMI 9902, Laboratoire d'Otologie NeuroOtologie, Faculté de Médecine Nord, Université la Méditerranée Aix-Marseille II, Boulevard Pierre Dramard, 13916 Marseille Cedex 20, France.
| |
Collapse
|
186
|
Rodríguez-Ballesteros M, del Castillo FJ, Martín Y, Moreno-Pelayo MA, Morera C, Prieto F, Marco J, Morant A, Gallo-Terán J, Morales-Angulo C, Navas C, Trinidad G, Tapia MC, Moreno F, del Castillo I. Auditory neuropathy in patients carrying mutations in the otoferlin gene (OTOF). Hum Mutat 2003; 22:451-6. [PMID: 14635104 DOI: 10.1002/humu.10274] [Citation(s) in RCA: 148] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Inherited hearing impairment affects one in 2,000 newborns. Nonsyndromic prelingual forms are inherited mainly as autosomal recessive traits, for which 16 genes are currently known. Mutations in the genes encoding connexins 26 and 30 account for up to 50% of these cases. However, the individual contribution of the remaining genes to the whole remains undetermined. In addition, for most of the genes there is a need for studies on genotype-phenotype correlations, to identify distinctive clinical features which may direct the molecular diagnosis to specific genes. Here we present a mutation analysis and a genotype-phenotype correlation study on the gene encoding otoferlin (OTOF), responsible for the DFNB9 subtype of prelingual hearing impairment. Four novel mutations were identified: c.2122C>T (p.Arg708Ter), c.4275G>A (p.Trp1425Ter), c.4362+2T>G, and c.5860_5862delATC (p.Ile1954del). A total of 37 subjects with mutations in OTOF were studied clinically. They were phenotypically homogeneous, having profound hearing impairment with very early onset, as shown by pure-tone audiometry and auditory brainstem responses. Magnetic resonance imaging and computed tomography did not reveal any inner ear malformation. Unexpectedly, transient evoked otoacoustic emissions (TEOAEs) were present, either bilaterally or unilaterally in 11 subjects. Altogether, clinical data of these subjects met the diagnostic criteria of auditory neuropathy. A total of 10 subjects had been successfully provided with cochlear implants. The results of our study indicate that genetic diagnosis of subjects with auditory neuropathy and profound hearing impairment should be directed to the otoferlin gene. Our data are of concern to universal screening programs which use TEOAEs as the first detection test for hearing impairment in newborns, since this technique may overlook a nonnegligible proportion of cases.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Audiometry, Evoked Response/methods
- Child
- Child, Preschool
- Cochlea/diagnostic imaging
- Cochlea/pathology
- DNA/chemistry
- DNA/genetics
- DNA Mutational Analysis
- Diagnostic Techniques, Otological
- Evoked Potentials, Auditory, Brain Stem/physiology
- Female
- Genotype
- Hearing Loss, Sensorineural/diagnosis
- Hearing Loss, Sensorineural/genetics
- Hearing Loss, Sensorineural/physiopathology
- Humans
- Infant
- Male
- Membrane Proteins/genetics
- Middle Aged
- Mutation
- Otoacoustic Emissions, Spontaneous
- Phenotype
- Radiography
Collapse
|
187
|
Zhu M, Yang T, Wei S, DeWan AT, Morell RJ, Elfenbein JL, Fisher RA, Leal SM, Smith RJH, Friderici KH. Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26). Am J Hum Genet 2003; 73:1082-91. [PMID: 13680526 PMCID: PMC1180488 DOI: 10.1086/379286] [Citation(s) in RCA: 145] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2003] [Accepted: 08/14/2003] [Indexed: 12/11/2022] Open
Abstract
Age-related hearing loss (presbycusis) is a significant problem in the population. The genetic contribution to age-related hearing loss is estimated to be 40%-50%. Gene mutations that cause nonsyndromic progressive hearing loss with early onset may provide insight into the etiology of presbycusis. We have identified four families segregating an autosomal dominant, progressive, sensorineural hearing loss phenotype that has been linked to chromosome 17q25.3. The critical interval containing the causative gene was narrowed to approximately 2 million bp between markers D17S914 and D17S668. Cochlear-expressed genes were sequenced in affected family members. Sequence analysis of the gamma-actin gene (ACTG1) revealed missense mutations in highly conserved actin domains in all four families. These mutations change amino acids that are conserved in all actins, from protozoa to mammals, and were not found in >100 chromosomes from normal hearing individuals. Much of the specialized ultrastructural organization of the cells in the cochlea is based on the actin cytoskeleton. Many of the mutations known to cause either syndromic or nonsyndromic deafness occur in genes that interact with actin (e.g., the myosins, espin, and harmonin). The mutations we have identified are in various binding domains of actin and are predicted to mildly interfere with bundling, gelation, polymerization, or myosin movement and may cause hearing loss by hindering the repair or stability of cochlear cell structures damaged by noise or aging. This is the first description of a mutation in cytoskeletal, or nonmuscle, actin.
Collapse
Affiliation(s)
- M Zhu
- Department of Microbiology & Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
188
|
Hirokawa N, Takemura R. Biochemical and molecular characterization of diseases linked to motor proteins. Trends Biochem Sci 2003; 28:558-65. [PMID: 14559185 DOI: 10.1016/j.tibs.2003.08.006] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Recent studies have revealed that kinesin, dynein and myosin each form large superfamilies and participate in many different intracellular transport systems. Importantly, these motor proteins play significant roles in the pathogenesis of a variety of diseases. Studies using knockout mice for kinesin KIF1B have led to the identification of the cause of a human hereditary neuropathy, Charcot-Marie-Tooth disease type 2A. The function of members of the dynein superfamily whose existence has previously only been confirmed through genome databases, has been revealed by studies of immotile cilia syndrome. Unconventional myosins have been shown to function in the inner-ear cells by examination of hereditary human hearing impairment and studies using mouse models. In addition, some diseases are caused by mutations, not in the motor itself, but in the proteins associated with the motor proteins. Here, we discuss the relationship of these motor proteins and how they contribute to disease in molecular terms.
Collapse
Affiliation(s)
- Nobutaka Hirokawa
- Department of Cell Biology and Anatomy, Graduate School of Medicine, University of Tokyo, Hongo, 7-3-1, Bunkyo-ku, 113-0033, Tokyo, Japan.
| | | |
Collapse
|
189
|
Delmaghani S, Aghaie A, Compain-Nouaille S, Ataie A, Lemainque A, Zeinali S, Lathrop M, Weil D, Petit C. DFNB40, a recessive form of sensorineural hearing loss, maps to chromosome 22q11.21–12.1. Eur J Hum Genet 2003; 11:816-8. [PMID: 14512974 DOI: 10.1038/sj.ejhg.5201045] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
We report on a novel localization for a recessive form of deafness (DFNB), by linkage analysis in an Iranian consanguineous family. Affected individuals suffer from prelingual profound sensorineural hearing loss. Genome-wide analysis led to the characterization of a new locus, DFNB40, which maps to an approximately 9 Mb interval between markers D22S427 and D22S1144 at chromosome 22q11.21-12.1. Maximum lod score of 3.09 was obtained with D22S1174. Since the Bronx waltzer (bv) mouse mutant, characterized by waltzing behavior, deafness, and degeneration of cochlear inner hair cells, has been mapped to the syntenic region on murine chromosome 5, we suggest that DFNB40 and bv may result from orthologous gene defects.
Collapse
Affiliation(s)
- Sedigheh Delmaghani
- Unité de Génétique des Déficits Sensoriels, INSERM U587, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris cedex 15, France
| | | | | | | | | | | | | | | | | |
Collapse
|
190
|
Noben-Trauth K, Zheng QY, Johnson KR. Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat Genet 2003; 35:21-3. [PMID: 12910270 PMCID: PMC2864026 DOI: 10.1038/ng1226] [Citation(s) in RCA: 355] [Impact Index Per Article: 16.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2003] [Accepted: 07/23/2003] [Indexed: 11/09/2022]
Abstract
Age-related hearing loss (AHL) in common inbred mouse strains is a genetically complex quantitative trait. We found a synonymous single-nucleotide polymorphism in exon 7 of Cdh23 that shows significant association with AHL and the deafness modifier mdfw (modifer of deafwaddler). The hypomorphic Cdh23(753A) allele causes in-frame skipping of exon 7. Altered adhesion or reduced stability of CDH23 may confer susceptibility to AHL. Homozygosity at Cdh23(753A) or in combination with heterogeneous secondary factors is a primary determinant of AHL in mice.
Collapse
Affiliation(s)
- Konrad Noben-Trauth
- Section on Neurogenetics, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, 5 Research Court, Rockville, Maryland 20850, USA.
| | | | | |
Collapse
|
191
|
Abstract
Given the unique biological requirements of sound transduction and the selective advantage conferred upon a species capable of sensitive sound detection, it is not surprising that up to 1% of the approximately 30,000 or more human genes are necessary for hearing. There are hundreds of monogenic disorders for which hearing loss is one manifestation of a syndrome or the only disorder and therefore is nonsyndromic. Herein we review the supporting evidence for identifying over 30 genes for dominantly and recessively inherited, nonsyndromic, sensorineural deafness. The state of knowledge concerning their biological roles is discussed in the context of the controversies within an evolving understanding of the intricate molecular machinery of the inner ear.
Collapse
Affiliation(s)
- Thomas B Friedman
- Laboratory of Molecular Genetics, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, Maryland 20850, USA.
| | | |
Collapse
|
192
|
|
193
|
Abstract
The molecular mechanisms for the transduction of light and chemical signals in animals are fairly well understood. In contrast, the processes by which the senses of touch, balance, hearing, and proprioception are transduced are still largely unknown. Biochemical approaches to identify transduction components are difficult to use with mechanosensory systems, but genetic approaches are proving more successful. Genetic research in several organisms has demonstrated the importance of cytoskeletal, extracellular, and membrane components for sensory mechanotransduction. In particular, researchers have identified channel proteins in the DEG/ENaC and TRP families that are necessary for signaling in a variety of mechanosensory cells. Proof that these proteins are components of the transduction channel, however, is incomplete.
Collapse
Affiliation(s)
- Glen G Ernstrom
- Department of Biological Sciences, 1012 Fairchild Center, Columbia University, 1212 Amsterdam Avenue, New York, NY 10027, USA.
| | | |
Collapse
|
194
|
Uyguner O, Emiroglu M, Uzumcu A, Hafiz G, Ghanbari A, Baserer N, Yuksel-Apak M, Wollnik B. Frequencies of gap- and tight-junction mutations in Turkish families with autosomal-recessive non-syndromic hearing loss. Clin Genet 2003; 64:65-9. [PMID: 12791041 DOI: 10.1034/j.1399-0004.2003.00101.x] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Mutations in genes encoding gap- and tight-junction proteins have been shown to cause distinct forms of hearing loss. We have now determined the GJB2[connexin 26 (Cx26)] mutation spectrum in 60 index patients from mostly large Turkish families with autosomal-recessive inherited non-syndromic sensorineural hearing loss (NSSHL). GJB2 mutations were found in 31.7% of the families, and the GJB2-35delG mutation accounted for 73.6% of all GJB2 mutations. The carrier frequency of GJB2-35delG in the normal Turkish population was found to be 1.17% (five in 429). In addition to the described W24X, 233delC, 120delE and R127H mutations, we also identified a novel mutation, Q80R, in the GJB2 gene. Interestingly, the Q80R allele was inherited on the same haplotype as V27I and E114G polymorphisms. As little is known about the mutation frequencies of most other recently identified gap- and tight-junction genes as a cause for hearing loss, we further screened our patients for mutations in GJB3 (Cx31), GJA1 (Cx43), DeltaGJB6-D13S1830 (Cx30) and the gene encoding the tight-junction protein, claudin 14 (CLDN14). Several novel polymorphisms, but no disease-associated mutations, were identified in the CLND14 and GJA1 genes, and we were unable to detect the DeltaGJB6-D13S1830 deletion. A novel putative mutation, P223T, was found in the GJB3 gene in heterozygous form in a family with two affected children. Our data shows that the frequency of GJB2 mutations in Turkish patients with autosomal-recessive NSSHL and the carrier rate of the GJB2-35delG mutation in the Turkish population, is much lower than described for other Mediterranean countries. Furthermore, mutations in other gap- and tight-junction proteins are not a frequent cause of hearing loss in Turkey.
Collapse
Affiliation(s)
- O Uyguner
- Division of Medical Genetics, Child Health Institute, Istanbul University, Istanbul, Turkey.
| | | | | | | | | | | | | | | |
Collapse
|
195
|
Abstract
Mechanosensation has been studied for decades, but understanding of its molecular mechanism is only now emerging from studies in Caenorhabditis elegans and Drosophila melanogaster. In both cases, the entry point proved to be genetic screens that allowed molecules needed for mechanosensation to be identified without any prior understanding of the likely components. In C. elegans, genetic screens revealed molecules needed for touch sensation along the body wall and other regions of force sensitivity. Members of two extensive membrane protein families have emerged as candidate sensory mechanotransduction channels: mec-4 and mec-10, which encode amiloride-sensitive channels (ASCs or DEG/ENaCs), and osm-9, which encodes a TRP ion channel. There are roughly 50 other members of these families whose functions in C. elegans are unknown. This article classifies these channels in C. elegans, with an emphasis on insights into their function derived from mutation. We also review the neuronal cell types in which these channels might be expressed and mediate mechanotransduction.
Collapse
Affiliation(s)
- Miriam B Goodman
- Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, USA.
| | | |
Collapse
|
196
|
Ahmed ZM, Morell RJ, Riazuddin S, Gropman A, Shaukat S, Ahmad MM, Mohiddin SA, Fananapazir L, Caruso RC, Husnain T, Khan SN, Riazuddin S, Griffith AJ, Friedman TB, Wilcox ER. Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet 2003; 72:1315-22. [PMID: 12687499 PMCID: PMC1180285 DOI: 10.1086/375122] [Citation(s) in RCA: 138] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2003] [Accepted: 02/25/2003] [Indexed: 11/03/2022] Open
Abstract
Cosegregation of profound, congenital deafness with markers on chromosome 6q13 in three Pakistani families defines a new recessive deafness locus, DFNB37. Haplotype analyses reveal a 6-cM linkage region, flanked by markers D6S1282 and D6S1031, that includes the gene encoding unconventional myosin VI. In families with recessively inherited deafness, DFNB37, our sequence analyses of MYO6 reveal a frameshift mutation (36-37insT), a nonsense mutation (R1166X), and a missense mutation (E216V). These mutations, along with a previously published missense allele linked to autosomal dominant progressive hearing loss (DFNA22), provide an allelic spectrum that probes the relationship between myosin VI dysfunction and the resulting phenotype.
Collapse
Affiliation(s)
- Zubair M. Ahmed
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Robert J. Morell
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Saima Riazuddin
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Andrea Gropman
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Shahzad Shaukat
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Mussaber M. Ahmad
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Saidi A. Mohiddin
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Lameh Fananapazir
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Rafael C. Caruso
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Tayyab Husnain
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Shaheen N. Khan
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Sheikh Riazuddin
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Andrew J. Griffith
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Thomas B. Friedman
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| | - Edward R. Wilcox
- Section on Human Genetics, Section on Gene Structure and Function, Laboratory of Molecular Genetics, and Hearing Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, MD; National Center of Excellence in Molecular Biology, Punjab University, Lahore, Pakistan; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, and Department of Neurology, Children’s National Medical Center, Washington, D.C.; and Clinical Cardiology Section, National Heart, Lung and Blood Institute, and Section on Ophthalmic Molecular Genetics, National Eye Institute, National Institutes of Health, Bethesda
| |
Collapse
|
197
|
Lavigne-Rebillard M, Delprat B, Surget MO, Griffoin JM, Weil D, Arbones M, Vincent R, Hamel CP. Gene structure, chromosomal localization, and mutation screening of the human gene for the inner ear protein otospiralin. Neurogenetics 2003; 4:137-40. [PMID: 12687421 DOI: 10.1007/s10048-003-0145-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2003] [Accepted: 02/17/2003] [Indexed: 10/25/2022]
Abstract
Otospiralin is a novel protein of unknown function that is produced by non-sensory cells (fibrocytes) of the inner ear (cochlea and vestibule). We showed that downregulation of otospiralin in guinea pigs leads to deafness and we therefore hypothesized that genetic defects in the otospiralin gene could also cause deafness in humans. In this study, we cloned and localized OTOSP, the human gene for otospiralin. OTOSP spans 1630 nucleotides, contains four exons and codes for a 567-nucleotide cDNA. By fluorescence in situ hybridization and hybrid panel mapping we localized OTOSP on chromosome 2 at position q37.3. There is currently no deafness family linked to this region. We screened OTOSP for mutations in 410 unrelated patients exhibiting various levels of hearing loss. Beside intronic polymorphisms, a rare variant (Pro7Leu) was found in 4 deafness patients and 3 control individuals, indicating that this change is not involved in this condition and excluding OTOSP as a major gene for genetic deafness.
Collapse
Affiliation(s)
- Mireille Lavigne-Rebillard
- Physiopathologie et Thérapie des Déficits Sensoriels et Moteurs, INSERM U 583, 71 rue de Navacelles, 34090 Montpellier, France
| | | | | | | | | | | | | | | |
Collapse
|
198
|
Bruzzone R, Veronesi V, Gomès D, Bicego M, Duval N, Marlin S, Petit C, D'Andrea P, White TW. Loss-of-function and residual channel activity of connexin26 mutations associated with non-syndromic deafness. FEBS Lett 2003; 533:79-88. [PMID: 12505163 DOI: 10.1016/s0014-5793(02)03755-9] [Citation(s) in RCA: 126] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Connexins are the protein subunits of gap junction channels that allow a direct signaling pathway between networks of cells. The specific role of connexin channels in the homeostasis of different organs has been validated by the association of mutations in several human connexins with a variety of genetic diseases. Several connexins are present in the mammalian cochlea and at least four of them have been proposed as genes causing sensorineural hearing loss. We have started our functional analysis by selecting nine mutations in Cx26 that are associated with non-syndromic recessive deafness (DFNB1). We have observed that both human Cx26 wild-type (HCx26wt) and the F83L polymorphism, found in unaffected controls, generated electrical conductance between paired Xenopus oocytes, which was several orders of magnitude greater than that measured in water-injected controls. In contrast, most recessive Cx26 mutations (identified in DFNB1 patients) resulted in a simple loss of channel activity. In addition, the V37I mutation, originally identified as a polymorphism in heterozygous unaffected individuals, was devoid of function and thus may be pathologically significant. Unexpectedly, we have found that the recessive mutation V84L retained functional activity in both paired Xenopus oocytes and transfected HeLa cells. Furthermore, both the magnitude of macroscopic junctional conductance and its voltage-gating properties were indistinguishable from those of HCx26wt. The identification of functional differences of disease causing mutations may lead to define which permeation or gating properties of Cx26 are necessary for normal auditory function in humans and will be instrumental in identifying the molecular steps leading to DFNB1.
Collapse
Affiliation(s)
- R Bruzzone
- Departement of Neuroscience, Institut Pasteur, 75015, Paris,
| | | | | | | | | | | | | | | | | |
Collapse
|
199
|
Wallis D, Hamblen M, Zhou Y, Venken KJT, Schumacher A, Grimes HL, Zoghbi HY, Orkin SH, Bellen HJ. The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival. Development 2003; 130:221-32. [PMID: 12441305 DOI: 10.1242/dev.00190] [Citation(s) in RCA: 190] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Gfi1 was first identified as causing interleukin 2-independent growth in T cells and lymphomagenesis in mice. Much work has shown that Gfi1 and Gfi1b, a second mouse homolog, play pivotal roles in blood cell lineage differentiation. However, neither Gfi1 nor Gfi1b has been implicated in nervous system development, even though their invertebrate homologues, senseless in Drosophila and pag-3 in C. elegans are expressed and required in the nervous system. We show that Gfi1 mRNA is expressed in many areas that give rise to neuronal cells during embryonic development in mouse, and that Gfi1 protein has a more restricted expression pattern. By E12.5 Gfi1 mRNA is expressed in both the CNS and PNS as well as in many sensory epithelia including the developing inner ear epithelia. At later developmental stages, Gfi1 expression in the ear is refined to the hair cells and neurons throughout the inner ear. Gfi1 protein is expressed in a more restricted pattern in specialized sensory cells of the PNS, including the eye, presumptive Merkel cells, the lung and hair cells of the inner ear. Gfi1 mutant mice display behavioral defects that are consistent with inner ear anomalies, as they are ataxic, circle, display head tilting behavior and do not respond to noise. They have a unique inner ear phenotype in that the vestibular and cochlear hair cells are differentially affected. Although Gfi1-deficient mice initially specify inner ear hair cells, these hair cells are disorganized in both the vestibule and cochlea. The outer hair cells of the cochlea are improperly innervated and express neuronal markers that are not normally expressed in these cells. Furthermore, Gfi1 mutant mice lose all cochlear hair cells just prior to and soon after birth through apoptosis. Finally, by five months of age there is also a dramatic reduction in the number of cochlear neurons. Hence, Gfi1 is expressed in the developing nervous system, is required for inner ear hair cell differentiation, and its loss causes programmed cell death.
Collapse
Affiliation(s)
- Deeann Wallis
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
200
|
Macgregor S, Visscher PM, Knott S, Porteous D, Muir W, Millar K, Blackwood D. Is Schizophrenia Linked to Chromosome 1q? Science 2002. [DOI: 10.1126/science.1075331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- Stuart Macgregor
- Institute of Cell, Animal and Population Biology
Ashworth Laboratory
University of Edinburgh
West Mains Road
Edinburgh, EH9 3JT, UK
E-mail:
| | | | | | - David Porteous
- Department of Medical Genetics
Molecular Medicine Centre
University of Edinburgh
Crewe Road
Edinburgh, EH4 2XU, UK
| | - Walter Muir
- Department of Psychiatry
Kennedy Tower
University of Edinburgh
Morningside Park
Edinburgh, EH10 5HF, UK
| | - Kirsty Millar
- Department of Medical Genetics, Molecular Medicine Centre
| | | |
Collapse
|